Related references
Note: Only part of the references are listed.After the storm: an objective appraisal of the efficacy of c-kit plus cardiac progenitor cells in preclinical models of heart disease
Roberto Bolli et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2021)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Inflammation in Heart Failure JACC State-of-the-Art Review
Sean P. Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Extracellular Matrix in Ischemic Heart Disease, Part 4/4
Nikolaos G. Frangogiannis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure A Review of Biological Plausibility and Implementation of Flexible Clinical Trial Design
Kenneth M. Borow et al.
CIRCULATION RESEARCH (2019)
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure)
Roberto Bolli et al.
CIRCULATION RESEARCH (2018)
New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types
Marcin Wysoczynki et al.
CIRCULATION RESEARCH (2018)
Clinical Studies of Cell Therapy in Cardiovascular Medicine Recent Developments and Future Directions
Monisha N. Banerjee et al.
CIRCULATION RESEARCH (2018)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Karen A. Hicks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Global position paper on cardiovascular regenerative medicine
Francisco Fernandez-Aviles et al.
EUROPEAN HEART JOURNAL (2017)
The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016
Anthony Mathur et al.
EUROPEAN HEART JOURNAL (2017)
C-Kit Positive Cardiac Stem Cells and one Marrow Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner
Luer Bao et al.
JOURNAL OF CARDIAC FAILURE (2017)
Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction Twelve Months CMR and Long-Term Clinical Results
Daniel Surder et al.
CIRCULATION RESEARCH (2016)
Long-Term Outcome of Administration of c-kitPOS Cardiac Progenitor Cells After Acute Myocardial Infarction Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year
Xian-Liang Tang et al.
CIRCULATION RESEARCH (2016)
Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy
Yukichi Tokita et al.
CIRCULATION RESEARCH (2016)
Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Studies
Peter Paul Zwetsloot et al.
CIRCULATION RESEARCH (2016)
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial
Amit N. Patel et al.
LANCET (2016)
String Theory of c-kitpos Cardiac Cells A New Paradigm Regarding the Nature of These Cells That May Reconcile Apparently Discrepant Results
Matthew C. L. Keith et al.
CIRCULATION RESEARCH (2015)
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure
Emerson C. Perin et al.
CIRCULATION RESEARCH (2015)
Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease
Vasileios Karantalis et al.
CIRCULATION RESEARCH (2015)
Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)
Anders Bruun Mathiasen et al.
EUROPEAN HEART JOURNAL (2015)
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy
Vasileios Karantalis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Karen A. Hicks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Safety and Efficacy of Ixmyelocel-T An Expanded, Autologous Multi-Cellular Therapy, in Dilated Cardiomyopathy
Timothy D. Henry et al.
CIRCULATION RESEARCH (2014)
Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting
Vasileios Karantalis et al.
CIRCULATION RESEARCH (2014)
Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy The TAC-HFT Randomized Trial
Alan W. Heldman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
c-kit+ cells minimally contribute cardiomyocytes to the heart
Jop H. van Berlo et al.
NATURE (2014)
c-kit plus Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart
Kyung U. Hong et al.
PLOS ONE (2014)
Phase II Clinical Research Design in Cardiology Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Network (CCTRN)
Joshua M. Hare et al.
CIRCULATION (2013)
Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After Myocardial Infarction
Adam R. Williams et al.
CIRCULATION (2013)
Cell Therapy for Heart Failure A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions
Santosh K. Sanganalmath et al.
CIRCULATION RESEARCH (2013)
Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction The TIME Randomized Trial
Jay H. Traverse et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy The POSEIDON Randomized Trial
Joshua M. Hare et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy Functional Recovery and Reverse Remodeling
Adam R. Williams et al.
CIRCULATION RESEARCH (2011)
Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function The LateTIME Randomized Trial
Jay H. Traverse et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation
Konstantinos E. Hatzistergos et al.
CIRCULATION RESEARCH (2010)
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
Karl H. Schuleri et al.
EUROPEAN HEART JOURNAL (2009)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
Joshua M. Hare et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity
Henry C. Quevedo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Early improvement in cardiac tissue perfusion due to mesenchymal stem cells
Karl H. Schuleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy
Luciano C. Amado et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction
LC Amado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
